Skip to content

Clinical trials

Completed Carcinoma, Bronchogenic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Status: Completed Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20121
20131
20161
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lee Moffitt Cancer Center and Research Institute1
Hoffmann-La Roche1
National Institutes of Health Clinical Center (CC)1
NovaRx Corporation1
Pharmacyclics LLC.1
Revolution Medicines, Inc.1
Syndax Pharmaceuticals1
Valerio Therapeutics1
Weill Medical College of Cornell University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic9
Lung Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Neoplasms6
Neoplasms by Site5
Respiratory Tract Diseases5
Respiratory Tract Neoplasms5
Thoracic Neoplasms5
Bronchial Neoplasms4
Lung Diseases4

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.